Shigeo Takahashi
Papers
1
Total Citations
2
H-Index
1
About
Shigeo Takahashi is a leading authority in thoracic oncology, with a specialized focus on thymic epithelial tumors and lung cancer management. His most cited work, the 2025 publication "Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine," specifically Chapter 3 on guidelines for thymic epithelial tumors, has already garnered 2 citations, reflecting its immediate impact on clinical practice. Takahashi's major contribution lies in synthesizing evidence-based recommendations that standardize treatment approaches for these rare and complex malignancies, bridging gaps between surgical, medical, and radiation oncology. His work is instrumental in shaping national guidelines for the Japan Lung Cancer Society, ensuring that clinicians have clear, actionable protocols for managing thymic tumors and associated conditions. Beyond this landmark guideline, Takahashi's research advances personalized therapy strategies, integrating molecular profiling with traditional staging to improve patient outcomes. His dedication to evidence synthesis and clinical translation makes him a pivotal figure in thoracic oncology, guiding both current practice and future research directions for students and practitioners alike.
Research Focus
Key Achievements
Top Papers
- 1